These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18307172)

  • 1. Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.
    Karagiannis ED; Popel AS
    J Cell Biochem; 2008 Jul; 104(4):1356-63. PubMed ID: 18307172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides derived from type I thrombospondin repeat-containing proteins of the CCN family inhibit proliferation and migration of endothelial cells.
    Karagiannis ED; Popel AS
    Int J Biochem Cell Biol; 2007; 39(12):2314-23. PubMed ID: 17707681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer.
    Matsuo Y; Raimondo M; Woodward TA; Wallace MB; Gill KR; Tong Z; Burdick MD; Yang Z; Strieter RM; Hoffman RM; Guha S
    Int J Cancer; 2009 Sep; 125(5):1027-37. PubMed ID: 19431209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
    Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
    Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
    Strieter RM; Polverini PJ; Kunkel SL; Arenberg DA; Burdick MD; Kasper J; Dzuiba J; Van Damme J; Walz A; Marriott D
    J Biol Chem; 1995 Nov; 270(45):27348-57. PubMed ID: 7592998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokines in angiogenesis.
    Belperio JA; Keane MP; Arenberg DA; Addison CL; Ehlert JE; Burdick MD; Strieter RM
    J Leukoc Biol; 2000 Jul; 68(1):1-8. PubMed ID: 10914483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC chemokines in angiogenesis relevant to chronic fibroproliferation.
    Strieter RM; Belperio JA; Burdick MD; Keane MP
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):23-6. PubMed ID: 15720231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic peptides identified in thrombospondin type I domains.
    Karagiannis ED; Popel AS
    Biochem Biophys Res Commun; 2007 Jul; 359(1):63-9. PubMed ID: 17531201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELR+ CXC chemokines in human milk.
    Maheshwari A; Christensen RD; Calhoun DA
    Cytokine; 2003 Nov; 24(3):91-102. PubMed ID: 14581003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CXC chemokines as regulators of angiogenesis.
    Strieter RM; Polverini PJ; Arenberg DA; Kunkel SL
    Shock; 1995 Sep; 4(3):155-60. PubMed ID: 8574748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
    Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
    Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticles stimulate angiogenesis by inducing ELR(+) CXC-chemokines in synovial fibroblasts.
    Reich N; Beyer C; Gelse K; Akhmetshina A; Dees C; Zwerina J; Schett G; Distler O; Distler JH
    J Cell Mol Med; 2011 Apr; 15(4):756-62. PubMed ID: 20219013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
    Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA
    Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokines in angiogenesis.
    Strieter RM; Burdick MD; Gomperts BN; Belperio JA; Keane MP
    Cytokine Growth Factor Rev; 2005 Dec; 16(6):593-609. PubMed ID: 16046180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer CXC chemokine networks and tumour angiogenesis.
    Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
    Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of the ELR motif in piscine ELR+CXC-like chemokine.
    Cai Z; Gao C; Zhang Y; Xing K
    Mar Biotechnol (NY); 2009; 11(4):505-12. PubMed ID: 19048342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and bioactivity analysis of a CXC ligand in black seabream Acanthopagrus schlegeli: the evolutionary clues of ELR+CXC chemokines.
    Zhonghua C; Chunpin G; Yong Z; Kezhi X; Yaou Z
    BMC Immunol; 2008 Nov; 9():66. PubMed ID: 18990254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic activity of PSA-derived peptides.
    Chadha KC; Nair B; Godoy A; Rajnarayanan R; Nabi E; Zhou R; Patel NR; Aalinkeel R; Schwartz SA; Smith GJ
    Prostate; 2015 Sep; 75(12):1285-99. PubMed ID: 25963523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.